Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
248 studies found for:    "ankylosing spondylitis"
Show Display Options
Rank Status Study
21 Completed Remicade in the Treatment of Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: Infliximab
22 Completed Effects of Cardiovascular Training in Individuals With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Behavioral: Cardiovascular Training
23 Completed A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Celecoxib 200 milligrams;   Drug: Celecoxib 400 milligrams;   Drug: diclofenac 50 milligrams
24 Completed A Study of Golimumab in Participants With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Placebo;   Drug: Golimumab
25 Completed Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Biological: AIN457A
26 Unknown  Etanercept (Enbrel) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: Etanercept
27 Completed Impact of Adalimumab (Humira) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice
Condition: Ankylosing Spondylitis
Intervention:
28 Recruiting A Multicenter Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Other: Placebo;   Drug: Bimekizumab
29 Active, not recruiting Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients
Condition: Ankylosing Spondylitis
Intervention:
30 Unknown  Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: abatacept
31 Not yet recruiting Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: BCD-085;   Other: Placebo
32 Unknown  Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: rituximab
33 Completed Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: infliximab;   Drug: methotrexate
34 Unknown  Prednisolone in Active Ankylosing Spondylitis (AS)
Condition: Ankylosing Spondylitis
Intervention: Drug: prednisolone
35 Unknown  16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Secukinumab (75 mg);   Drug: Secukinumab (150 mg);   Drug: Placebo
36 Completed Genetic Determinants of Ankylosing Spondylitis Severity
Condition: Ankylosing Spondylitis
Intervention:
37 Completed
Has Results
Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)
Condition: Ankylosing Spondylitis
Intervention:
38 Completed Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: diclophenac
39 Recruiting Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
Condition: Ankylosing Spondylitis
Intervention:
40 Completed Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach
Condition: Ankylosing Spondylitis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.